🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the efficacy and safety of probiotics for the p...
Status
Recruiting
Location
Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2025-08-07
Trial ID
NCT06892093
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2025-03-12
Trial ID
NCT06870058
Treatments Being Tested
The Zambia PCPI study will measure the effect of the parasite genotypes ass...
Status
Completed
Location
Nchelenge District
Start Date
2024-07-24
Trial ID
NCT06166498
Treatments Being Tested
The purpose of this study is to complete the total safety database size for...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-19
Trial ID
NCT03954743
This study will evaluate the skin pharmacokinetics and tolerability of bima...
Status
Completed
Location
DermResearch, LLC
Start Date
2016-07
Trial ID
NCT02848300
Treatments Being Tested
This phase I/II trial studies the side effects of panobinostat nanoparticle...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-05-22
Trial ID
NCT03566199
Treatments Being Tested
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
The primary objective of the study is to evaluate efficacy of entospletinib...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-14
Trial ID
NCT01799889
Treatments Being Tested
PF-06651600 is being developed for treatment of inflammatory bowel disease....
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2016-02
Trial ID
NCT02684760
Treatments Being Tested